Concepedia

John H. Schwerdt

JH

Statistics

Publications

13

Citations

336

H-Index

12

Active since

1990

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

AIL Research (United States)

LabCorp (United States)

John H. Schwerdt is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicinal chemistry, drug discovery, and pharmacy.

Publications per year

1990–2012

13

Publications

13

Cyclic urea derivatives as potent NK1 selective antagonists

Ho‐Jane Shue, Xiao Chen, Neng‐Yang Shih et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 47 citations

, , +4

Enantiomerization of an atropisomeric drug

Richard Friary, Michael Spangler, Rebecca Osterman et al. · Chirality · 1996 · 45 citations

, , +13

SAR studies of pyridazinone derivatives as novel glucan synthase inhibitors

Pauline C. Ting, Robert Aslanian, Jianhua Cao et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 35 citations · Full text

, , +7

Supercritical fluid chromatography/tandem mass spectrometric method for analysis of pharmaceutical compounds in metabolic stability samples

Yunsheng Hsieh, Leonard Favreau, John H. Schwerdt et al. · Journal of Pharmaceutical and Biomedical Analysis · 2005 · 33 citations

, , +11

Discovery of a highly potent series of oxazole-based phosphodiesterase 4 inhibitors

Rongze Kuang, Ho‐Jane Shue, David J. Blythin et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 33 citations · Full text

, , +14

1–5 of 13